通过新辅助疗法转化为可切除疾病的局部发达NSCLC患者的生存结果
Ece Duygu Gulsen1, Rashad Ismayilov2, Aydan Farzaliyeva3
1Department of Internal Medicine, Baskent University Faculty of Medicine, Ankara, Türkiye.
In vivo (Athens, Greece)
|January 2, 2026
概括
No abstract available in PubMed .


